News from us and our partners

Tags

Topics

0 results

News
22 April, 2024
Sofinnova’s newest partners discuss their career paths
News
22 April, 2024
Sofinnova Partners appoints two new partners, strengthening team of next generation investors
News
10 April, 2024
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
News
9 April, 2024
Artios Pharma appoints Chris Liu to board
News
8 April, 2024
Sensorion announces a €15 Million financing, extending cash runway until the end of 2025
News
5 April, 2024
Johnson & Johnson to acquire Shockwave Medical
News
3 April, 2024
Moon Surgical expands to gynecological surgery
News
28 March, 2024
Inventiva announces the nomination of Andre Turenne as Director
News
26 March, 2024
Asceneuron joins critical path for Alzheimer’s Disease Consortium
News
21 March, 2024
Mission Therapeutics commences landmark trial of MTX325, a potential disease-modifying treatment for Parkinson’s Disease
News
20 March, 2024
Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease
News
19 March, 2024
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated
News
19 March, 2024
Mainstay Medical announces publication of the first neuromodulation study for low back pain with 5-year follow-up
News
18 March, 2024
Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
News
18 March, 2024
Inventiva reports positive Phase 2 data for lanifibranor in MASH
News
14 March, 2024
Sofinnova Partners portfolio company Amolyt Pharma to be acquired by AstraZeneca

Sofinnova’s newest partners discuss their career paths

Sofinnova Partners appoints two new partners, strengthening team of next generation investors

Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis

Artios Pharma appoints Chris Liu to board

Sensorion announces a €15 Million financing, extending cash runway until the end of 2025

Johnson & Johnson to acquire Shockwave Medical

Moon Surgical expands to gynecological surgery

Inventiva announces the nomination of Andre Turenne as Director

Asceneuron joins critical path for Alzheimer’s Disease Consortium

Mission Therapeutics commences landmark trial of MTX325, a potential disease-modifying treatment for Parkinson’s Disease

Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease

Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated

Mainstay Medical announces publication of the first neuromodulation study for low back pain with 5-year follow-up

Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG

Inventiva reports positive Phase 2 data for lanifibranor in MASH

Sofinnova Partners portfolio company Amolyt Pharma to be acquired by AstraZeneca